Trump administration presses Congress to cut drug prices by ending industry's 'backdoor deals'
February 01, 2019 at 09:00 AM EST
The Trump administration calls on Congress to pass its proposed ban on "backdoor deals" pharmaceutical companies cut with middlemen who get preferred status for their drugs in Medicare prescription plans.
